← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2011Last known activity
Sep 1, 2016
Acquired by Avant Immunotherapeutics → Celldex Therapeutics on Mar 1, 2016
Timeline
2000s
- Jan 1, 2008
Amarantus BioScience Holdings, Inc.— Founded
- Jan 1, 2008
Celldex Therapeutics— Now
2010s
- Mar 1, 2016
Avant Immunotherapeutics— Acquired By
Drugs by trial phase (2 distinct, 3 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT01655407Lead sponsorPhase 2Sep 1, 2016
- NCT02439125Study directorPhase 2May 1, 2015
- NCT02439125Lead sponsorPhase 2May 1, 2015
- NCT01266174Lead sponsorPhase 2Aug 1, 2011
Details
- Founded
- New York, NY, US Jan 1, 2008
- Last known activity
- Sep 1, 2016